CRESTONE INC holds $20.9M across 4 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 12 offers. Set-aside status: NONE. Recompete timing centers on the Jan 31, 2027 PoP end — agencies typically plan 12–18 months ahead.
TO PERFORM THE EVALUATION OF SAFETY AND EFFICACY OF CRS3123 TO TREAT CLOSTRIDIUM DIFFICILE INFECTIONS.
Current PoP ends Jan 31, 2027 (188 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.
Track recompete timing in SCOUT →CRESTONE INC — $20.9M obligated across 4 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Live Demand-Fit + Displacement scoring, alerts on verdict flips, and watchlists. Free — no card required.
See all live recompete landscapes — who else is expiring, and where the openings are.
Open CRESTONE INC’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Register free to start exploring SCOUT →